Agnese, Suppiej
Chiara, Ceccato
Radouil, Tzekov
Iveta, Cermakova
Francesco, Parmeggiani
Gianmarco, Bellucci
Marco, Salvetti
Theresa, Zesiewicz
Giovanni, Ristori
Silvia, Romano
Funding for this research was provided by:
Università degli Studi di Ferrara
Article History
Accepted: 17 June 2024
First Online: 8 July 2024
Declarations
:
: The Institutional Review Board of the Robert Hollman Foundation (protocol number 8/2017) approved the study. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and data obtained for clinical purposes to monitor riluzole treatment on a compassionate use program were retrieved from institutional records of the participating centers and collected in an anonymized dataset. The written informed consent to compassionate use of riluzole was obtained from all participants included in the study or the legally authorized representative. Additional written informed consent regarding publishing their data was obtained from all individual participants.
: The authors declare no competing interests.